Enhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation

Pharmacotherapy

Volumn 16, Issue 1 I, 1996, Pages 59-65

  Pan, Shi Hui ^a,b   Lopez Jr , Richard R ^a   Sher, Linda S ^a   Hoffman, Allen L ^a   Podesta, Luis G ^a   Makowka, Leonard ^a   Rosenthal, Philip ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYCLOSPORIN; TOCOFERSOLAN;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; COST CONTROL; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFECT; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION;

ABSORPTION; ADMINISTRATION, ORAL; ADULT; BODY WEIGHT; CHILD, PRESCHOOL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; VITAMIN E;

EID: 0030028570     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kahan BD. Cyclosporine N Engl J Med 1989;321 (25):1725-38.
2. Copeland KR, Yatscoff RW. Immunosuppressive activity and toxicity of cyclosporine metabolites characterized by mass spectroscopy and nuclear magnetic resonance Transplant Proc 1990;22(3):1146-9.
3. Rodighiero V. Therapeutic drug monitoring of cyclosporine - practical applications and limitations. Clin Pharmacokinet 1989,16:27-37.
4. Lindholm A, Henricsson S, Dahlquist R. The effect of food and bile acid administration on the relative bioavailability of cyclosporine. Br J Clin Pharmacol 1990;29:541-8.
5. Whitington PF, Emond JC, Whitington SH, et al. Small-bowel length and the dose of cyclosporine in children after liver transplantation. N Engl J Med 1990;322:733-8.
6. Mehta MU, Venkataramanan R, Burckart GJ, et al. Effect of bile on cyclosporine absorption in liver transplant recipients Br J Clin Pharmacol 1988;25 579-84
7. Burckart GJ, Venkataramanan R, Ptachcinski RJ, et al. Cyclosporine absorption following orthotopic liver transplantation. J Clin Pharmacol 1986;26:647-51
8. Venkataramanan R, Ptachcinski R, Burckart GJ, et al Cyclosporine bioavailability in liver disease. Drug Intell Clin Pharm 1985,19.451.
9. Yee GC, McGuire TR Pharmacokinetic drug interactions with cyclosporine. Part I. Clin Pharmacokinet 1990;19(4):319-32.
10. Yee GC, McGuire TR. Pharmacokinetic drug interactions with cyclosporine Part II Clin Pharmacokmet 1990;19(5):400-15.
11. Sokol RJ, Heubi JE, Butler-Simon N, et al. Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-alpha-tocopheryl polyethylene glycol-1000 succinate. Gastroenterology 1987,93:975-85.
12. Sokol RJ, Butler-Simon N, Conner C, et al. Multi-center trial of d-alpha-tocopheryl polyethylene glycol-1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. Gastroenterology 1993,104(6):1727-35.
13. Yee GC, Lennon TP, Gmur DJ, et al. Age-dependent cyclosporine, pharmacokinetics in bone marrow transplant recipients. Clin Pharmacol Ther 1986;40:438-43.
14. Warwick WJ. Diet for cystic fibrosis: nutritional requirements and prescriptions. Postgrad Med 1987;82(8):121-9.
15. Pan SH, Canafax DM. The pathophysiology and current treatment of patients with cystic fibrosis. Minn Pharm 1988;42:6-14.
16. Sokol RJ, Johnson KE, Karrer FM, et al. Improvement of cyclosporine absorption in children after liver transplantation by means of water-soluble vitamin E. Lancet 1991;338:212-15.
17. Boudreaux JP, Hayes DH, Mizrahi S, et al. Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. Transplant Proc 1993,25(2):1875.
18. Odlind B, Lindberg A, Tufveson G, et al. Longitudinal study of the pharmacokinetics of cyclosporine before and after renal transplantation. Transplant Proc 1986;18 47-9.
19. Hourmant M, Lebigot JF, Vernillet L, et al. Coadministration of erythromycin results in an increase of blood cyclosporine to toxic levels Transplant Proc 1985;17:2723-7.
20. Butman SM, Wild JC, Nolan PE, et al. Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 1991;10:351-8.
21. Smith CL, Hampton EM, Pederson JA, et al. Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients. Pharmacotherapy 1994;14(4):471-81.
22. Schaffer CB, Critchfield FH. The absorption and excretion of the solid polyethylene glycols ("Carbowax" compound). J Am Pharmacol Assoc 1947;36.152-7